Tumor dihydropyrimidine dehydrogenase in stage II and III colorectal cancer: low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples